AbbVie will buy Aliada Therapeutics for $1.4 billion in cash, it said on Monday, gaining access to the privately held therapy developer's Alzheimer's disease candidate as the U.S. drugmaker increases ...
3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever ... It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, ...
Learn about traditional Chinese medicine that believes diseases may arise due to a disharmony between the yin and the yang, the five basic constituents and/or the qi energy flowing through the body.
HC Wainwright reissued their neutral rating on shares of Alkermes (NASDAQ:ALKS – Free Report) in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has a $37.00 ...